author-photo

Gustavo Suarez

Bayer HealthCare Pharmaceuticals

20

Papers

213

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors

2016 Neurology and Therapy
Show All
- Source
- Cite
- Save
Citations (11)
Baseline Predictors of Disease Activity in Patients with CIS Treated with Interferon beta-1b in the BENEFIT 11 Trial (P2.121)

2016 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11)

2016 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (0)
Predicting conversion to clinically definite multiple sclerosis using machine learning on the basis of cerebral grey matter segmentations

2015 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of Multiple Sclerosis - Relationship between Vitamin D and Interferon β-1b

2015 European neurological review
Show All
- Source
- Cite
- Save
Citations (1)
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (35)
Vitamin D as a Predictor of Functional Deficits in Multiple Sclerosis (P4.014)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11)

2015 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (0)
MRI results in patients with CIS treated with interferon beta-1b: 11-year follow up in BENEFIT (BENEFIT 11)

2015 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (0)
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.

2015 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (3)